KANGHUA HEALTH (03689) · Company profile · Eqvero

KANGHUA HEALTH

03689HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	2.02 bn CNY	2.06 bn CNY	2.04 bn CNY	1.85 bn CNY	1.95 bn CNY
Cost of revenue	1.52 bn CNY	1.58 bn CNY	1.55 bn CNY	1.48 bn CNY	1.52 bn CNY
Research and development expense	1.59 m CNY	834 k CNY	589 k CNY	1.1 m CNY	835 k CNY
Selling, general and administrative expense	207.43 m CNY	277.1 m CNY	222.39 m CNY	188.02 m CNY	161.22 m CNY
Operating profit after depreciation	147.43 m CNY	40.39 m CNY	119.27 m CNY	29.24 m CNY	126.02 m CNY
Operating profit before depreciation	286.89 m CNY	191.24 m CNY	263.35 m CNY	178.68 m CNY	275.46 m CNY
EBIT	147.43 m CNY	40.39 m CNY	119.27 m CNY	29.24 m CNY	126.02 m CNY
EBITDA	286.89 m CNY	191.24 m CNY	263.35 m CNY	178.68 m CNY	275.46 m CNY
Interest expense	15.96 m CNY	11.95 m CNY	12.06 m CNY	28.3 m CNY	29.47 m CNY
Profit before tax	142.3 m CNY	63.06 m CNY	153.43 m CNY	69.31 m CNY	129.21 m CNY
Income tax expense	47.79 m CNY	52.58 m CNY	62.41 m CNY	41.57 m CNY	62.28 m CNY
Income before extraordinary items	99.59 m CNY	15.34 m CNY	121.06 m CNY	61.03 m CNY	94.31 m CNY
Common dividends	53.5 m CNY	50.16 m CNY	—	—	—
Total dividends	53.5 m CNY	50.16 m CNY	—	—	—

Quotes are end-of-day data. Content is for research purposes and is not investment advice.